We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Innovative PCR Lab Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022

Tianlong Science and Technology (Shaanxi, China) is showcasing its integrated PCR lab solution that empowers laboratories at the MEDICA 2022 International Trade Fair being held on November 14-17 in Düsseldorf, Germany. More...

Tianlong provides an innovative PCR lab solution from sample processing system, nucleic acid extractor, and PCR systems to compatible reagents, which has been accredited by many clients for its great performance and high stability. Within its integrated PCR lab solution being showcased at this year’s edition of MEDICA, is the Libex Nucleic Acid Extractor that can overcome the shortcomings of conventional nucleic acid extraction methods and achieve rapid and efficient sample preparation. With the appropriate nucleic acid extraction reagents, it can process serum, plasma, whole blood, swabs, amniotic fluid, feces, tissue and tissue lavage, paraffin sections, bacteria, fungi and other sample types. Also on display at the event is Tianlong’s new GeneMix Pro automatic sample processing system. Designed for automating laboratory workflow, GeneMix Pro can process 96 samples within 20 minutes and free professionals from tedious mechanical operations.

At MEDICA 2022, Tianlong is also highlighting the PANA S401/S201 automated pipetting workstation which is designed as an important tool for PCR setup and automates tedious, error-prone manual tasks, provides consistent sample mixing, and excellent pipetting performance to standardize results. In addition, visitors to Tianlong’s booth at MEDICA 2022 can experience the Gentier96E real time PCR detection system designed to meet the experimental needs of high-end users. Gentier96E offers various advantages including advanced efficient temperature control system and photoelectric system, powerful and easy-to-use software analysis function, and user-friendly control method, etc. It can easily process downstream multiplex gene detection, quantitative analysis, SNP analysis, dissociation curve analysis and other applications.

Tianlong is also demonstrating the Gentier 48 Real-time PCR System which is specially designed for small and medium-sized laboratories, mobile laboratories, field testing professionals and so on, to support absolute quantitative analysis, relative quantitative analysis, isothermal amplification, dissociation curve analysis, genotyping, and endpoint fluorescence analysis, etc. Alongside the Gentier 48, Tianlong is demonstrating the Gentier Mini portable Real-Time PCR System that is designed to meet the increasing needs for on-site and rapid testing. The Gentier Mini is compact and portable, easy to use, and highly efficient in real-time PCR testing with accurate temperature control, enabling real-time PCR tests out of the lab for all types of fields for various applications.

Related Links:
Tianlong Science and Technology 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Cell and Tissue Culture Plastics
Diamond® SureGro™ Cell and Tissue Culture Plastics
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.